Research Papers

25 of 284 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Edema related to treatment with psychotropic drugs.
Engel J; Haack B; Zolk O; Greiner T; Heinze M; Toto S; Seifert J; Bleich S; Glocker C; Grohmann R; Schneider M; Stübner S.
J Neural Transm (Vienna) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba…
Mueller JK; Müller WE.
J Neural Transm (Vienna) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Functional AGXT2 SNP rs180749 variant and depressive symptoms: Baseline data from the Aidai Cohort Study in Japan.
Kumon H; Miyake Y; Yoshino Y; Iga JI; Tanaka K; Senba H; Kimura E; Higaki T; Matsuura B; Kawamoto R; Ueno SI.
J Neural Transm (Vienna) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Parkinson's disease motor progression in relation to the timing of REM sleep behavior disorder presentation: an explora…
Bovenzi R; Pierantozzi M; Conti M; Carignani S; Fernandes M; Schirinzi T; Cerroni R; Mercuri NB; Stefani A; Liguori C.
J Neural Transm (Vienna) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Psychometric properties of the Caregiver's inventory neuropsychological diagnosis dementia (CINDD) in mild cognitive im…
Cuoco S; Blundo C; Ricci M; Cappiello A; Bisogno R; Carotenuto I; Avallone AR; Erro R; Pellecchia MT; Amboni M; Barone P; Picillo M.
J Neural Transm (Vienna) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Therapeutic use of medical Cannabis in neurological diseases: a clinical update.
Hidding U; Mainka T; Buhmann C.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Constipation and pain in Parkinson's disease: a clinical analysis.
Al-Wardat M; Grillo P; Schirinzi T; Pavese C; Salimei C; Pisani A; Natoli S.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Facial emotion expressivity in patients with Parkinson's and Alzheimer's disease.
Cannavacciuolo A; Paparella G; Salzillo M; Colella D; Canevelli M; Costa D; Birreci D; Angelini L; Guerra A; Ricciardi L; Bruno G; Berardelli A; Bologna M.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
L-DOPA-therapy in Parkinson's disease: some personal reflections on L-DOPA therapy from Vienna and Berlin.
Riederer P; Horowski R.
J Neural Transm (Vienna) (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
Excessive psychological stress preceding the onset of idiopathic cervical dystonia.
Dressler D; Kopp B; Pan L; Adib Saberi F.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The GlyT1-inhibitor Org 24598 facilitates the alcohol deprivation abolishing and dopamine elevating effects of bupropio…
Olsson Y; Lidö H; Ademar K; Cadeddu D; Ericson M; Söderpalm B.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Practical use of apomorphine infusion in Parkinson's disease: lessons from the TOLEDO study and clinical experience.
Henriksen T; Katzenschlager R; Bhidayasiri R; Staines H; Lockhart D; Lees A.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Practice behaviors as trigger factor for the onset of Musicians' Dystonia.
Passarotto E; Doll-Lee J; Altenmüller E; Lee A.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The homeless, seizures, and epilepsy: a review.
Pontes Silva R; Gama Marques J.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Oculometric measures as a tool for assessment of clinical symptoms and severity of Parkinson's disease.
Reiner J; Franken L; Raveh E; Rosset I; Kreitman R; Ben-Ami E; Djaldetti R.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Molecular signature of excessive female aggression: study of stressed mice with genetic inactivation of neuronal seroto…
Strekalova T; Moskvin O; Jain AY; Gorbunov N; Gorlova A; Sadovnik D; Umriukhin A; Cespuglio R; Yu WS; Tse ACK; Kalueff AV; Lesch KP; Lim LW.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Gender differences in non-motor fluctuations in Parkinson's disease.
Donzuso G; Cicero CE; Vinciguerra E; Sergi R; Luca A; Mostile G; Terravecchia C; Zappia M; Nicoletti A.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Subregion specific neuroadaptations in the female rat striatum during acute and protracted withdrawal from nicotine.
Lagström O; Vestin E; Söderpalm B; Ericson M; Adermark L.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Tools and criteria to select patients with advanced Parkinson's disease for device-aided therapies: a narrative review.
Moes HR; Henriksen T; Sławek J; Phokaewvarangkul O; Buskens E; van Laar T.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Access to device-aided therapies in advanced Parkinson's disease: navigating clinician biases, patient preference, and …
Auffret M; Weiss D; Stocchi F; Vérin M; Jost WH.
J Neural Transm (Vienna) (Unknown)
Published: 2023
2/6 Transparent
Clinimetrics of the Italian version of the Montreal Cognitive Assessment (MoCA) in adult-onset idiopathic focal dystoni…
D'Iorio A; Aiello EN; Trinchillo A; Silani V; Ticozzi N; Ciammola A; Poletti B; Esposito M; Santangelo G.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson's disease.
Jenner P; Falup-Pecurariu C; Leta V; Verin M; Auffret M; Bhidayasiri R; Weiss D; Borovečki F; Jost WH.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Fatigue in fluctuating Parkinson's disease patients: possible impact of safinamide.
Pauletti C; Locuratolo N; Mannarelli D; Maffucci A; Petritis A; Menini E; Fattapposta F.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The heterogeneity of Parkinson's disease.
Wüllner U; Borghammer P; Choe CU; Csoti I; Falkenburger B; Gasser T; Lingor P; Riederer P.
J Neural Transm (Vienna) (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
The heterogeneity of late-life depression and its pathobiology: a brain network dysfunction disorder.
Jellinger KA.
J Neural Transm (Vienna) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared